0.720
+0.020
(2.84%)
May 24 - Close
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 0.69 - 0.73 |
| 52 week | 0.63 - 2.78 |
| Open | 0.69 |
| Vol / Avg. | 25,589.00/113,477.00 |
| Mkt cap | 9.32M |
| P/E | - |
| Div/yield | - |
| EPS | -1.09 |
| Shares | 12.95M |
| Beta | 1.48 |
| Inst. own | 16% |
Events
Mar 22, 2013
Q4 2012 GenVec, Inc. Earnings Conference Call -
Mar 19, 2013
GenVec, Inc. at Roth Conference -
|
More events from DailyFinance »
|
Key stats and ratios
| Q4 (Dec '12) | 2012 | |
| Net profit margin | -207.69% | -150.27% |
| Operating margin | -208.42% | -150.72% |
| EBITD margin | - | -148.13% |
| Return on average assets | -66.91% | -59.08% |
| Return on average equity | -83.54% | -69.78% |
| Employees | 45 | - |
| Carbon Disclosure Rating | - | - |
Address
65 West Watkins Mill Road
GAITHERSBURG, MD 20878
United States - Map
+1-240-6320740 (Phone)
+1-240-6320735 (Fax)
GAITHERSBURG, MD 20878
United States - Map
+1-240-6320740 (Phone)
+1-240-6320735 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
GenVec, Inc. develops gene-based pharmaceuticals and therapies for the treatment of major medical needs. The Company combines its patented gene transfer technologies with proprietary therapeutic genes to create product candidates that address needs in the areas of cardiovascular disease, cancer and other therapeutic areas.
Officers and directors
| Zola P. Horovitz Ph.D. | Independent Chairman of the Board | |
| Cynthia Collins | President, Chief Executive Officer, Director | |
| Douglas J. Swirsky | Chief Financial Officer, Senior Vice President, Treasurer, Corporate Secretary | |
| Bryan T. Butman Ph.D. | Senior Vice President - Vector Operations | |
| Douglas E. Brough Ph.D. | Vice President - Head of Research | |
| Edward M. Connor Jr., M.D. | Independent Director | |
| Wayne T. Hockmeyer Ph.D. | Independent Director | |
| William N. Kelley M.D. | Independent Director | |
| Adel A. F. Mahmoud M.D., Ph.D. | Independent Director | |
| Kevin M. Rooney | Independent Director |